Upon completion, this acquisition will expand Lilly's growing U.S. capacity to produce the latest life-changing medicines INDIANAPOLIS and LINCOLNSHIRE, Ill., April 22, 2024 – Eli Lilly and Company (NYSE: LLY) and Nexus Pharmaceuticals, LLC today...
Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus Pharmaceuticals
read more...
